Zeria Pharmaceutical [clinicaltrials_resource:cbd36e06d9fd9c992c5abe0f7abcdcd9]
Safety and Tolerability of Z-100 in Patients With Early HIV Infection [clinicaltrials:NCT00016692]Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment [clinicaltrials:NCT00288925]The Effects of Z-338 in Subjects With and Without Functional Dyspepsia [clinicaltrials:NCT00298194]To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia [clinicaltrials:NCT00323817]To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia [clinicaltrials:NCT00333372]The Effect of Z-338 in Subjects With Functional Dyspepsia [clinicaltrials:NCT00458328]Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC) [clinicaltrials:NCT00731445]To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia [clinicaltrials:NCT00761358]Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets [clinicaltrials:NCT01237288]A Healthy Subject Study With Z-360 and Placebo [clinicaltrials:NCT01776463]Phase III, Long-term, Open-label Safety Study of Z-338 [clinicaltrials:NCT01973790]Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma [clinicaltrials:NCT02117258]Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia [clinicaltrials:NCT02170311]Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer [clinicaltrials:NCT02247232]To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis [clinicaltrials:NCT02463643]To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects [clinicaltrials:NCT02509923]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Safety and Tolerability of Z-100 in Patients With Early HIV Infection [clinicaltrials:NCT00016692]Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment [clinicaltrials:NCT00288925]The Effects of Z-338 in Subjects With and Without Functional Dyspepsia [clinicaltrials:NCT00298194]To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia [clinicaltrials:NCT00323817]To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia [clinicaltrials:NCT00333372]The Effect of Z-338 in Subjects With Functional Dyspepsia [clinicaltrials:NCT00458328]Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC) [clinicaltrials:NCT00731445]To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia [clinicaltrials:NCT00761358]Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets [clinicaltrials:NCT01237288]A Healthy Subject Study With Z-360 and Placebo [clinicaltrials:NCT01776463]Phase III, Long-term, Open-label Safety Study of Z-338 [clinicaltrials:NCT01973790]Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma [clinicaltrials:NCT02117258]Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia [clinicaltrials:NCT02170311]Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer [clinicaltrials:NCT02247232]To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis [clinicaltrials:NCT02463643]To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects [clinicaltrials:NCT02509923]
source [clinicaltrials_vocabulary:source]
Zeria Pharmaceutical [clinicaltrials_resource:cbd36e06d9fd9c992c5abe0f7abcdcd9]
Bio2RDF identifier
cbd36e06d9fd9c992c5abe0f7abcdcd9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:cbd36e06d9fd9c992c5abe0f7abcdcd9
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:cbd36e06d9fd9c992c5abe0f7abcdcd9
title
Zeria Pharmaceutical
@en
type
label
Zeria Pharmaceutical [clinicaltrials_resource:cbd36e06d9fd9c992c5abe0f7abcdcd9]
@en